Tagged antibodies
Press Release
Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™. Read More
Press Release
A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity
A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris. Read More
Press Release
Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference 'A-Wish'
Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new solution leverages the Hyris System™, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More
Press Release
Hyris Chalk Up Another Success Fighting COVID19, Providing Canadian Researchers and Medical Specialists With a New Test to Detect T-Cell Immune Response to SARS-CoV-2
Hyris developed a rapid T-Cell test to track patients' immunity levels to SARS-CoV-2 for global clinical and research use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the power of the renowned HYRIS bCUBE™ and the whole Hyris SystemTM. This disruptive platform enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More
Press Release
Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical
Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More
Press Release
Sweden's Most Promising Biotech Company Adopts Labscoop's eCommerce Engine to Deliver 18,000 Primary Antibodies to Researchers
The Labscoop application will allow Atlas Antibodies to highlight product quality, reliability and increase accessibility among US, European, and Canadian researchers. Read More
Press Release
Labscoop Welcomes Tonbo Biosciences as its Newest Marketplace Partner
Labscoop Welcomes Industry Leading Immunology Antibodies and Ancillary Reagents Manufacturer Tonbo Biosciences. One of the fastest growing life science companies offering high performance, value-oriented products of the highest quality. Read More
Press Release
OriGene Technologies Inc. Inks Antibody Sample Distribution Deal with One World Lab
OriGene announced today it has signed an agreement with One World Lab to become a global distributor of OriGene's antibody portfolio that includes premium branded UltraMAB® monoclonal antibodies, internally developed and validated through OriGene's protein high density chips for mono specificity, as well as TrueMAB® monoclonal antibodies that are generated with full length protein antigens. Read More
Press Release
Ebola Detection Using Rapid Tests and ELISA Kits for Humans and Animals
Ebola detection kits for humans and animals are now possible using ADI antibody or antigen ELISA kits with results in less than 2 hours. Ebola Rapid test cards, similar to pregnancy tests, have also been developed that provide results in 2-10 mins. Read More
Press Release
AbboMax Announces The Availability Of New Methyl-specific Antibodies
AbboMax offers nine novel anti- histone H3 antibodies specific for a mono-, di-, or tri-methylated state of Lys4, Lys9, and Lys27. Methylation is involved in regulation of gene expression, protein function and RNA metabolism Read More
Press Release
Novus Biologicals Announce New Beta Amyloid Pyroglutamate Antibodies
Novus Biologicals, a leading international supplier of high quality antibodies and proteins to the bioresearch industry, is pleased to announce the introduction of a new range of Beta Amyloid antibodies to their antibody catalogue. Read More
Press Release